PT85850B - Process for preparing 7-((meta-substituted) phenylglycine)-1-carba-1-dethiacephalosporins - Google Patents
Process for preparing 7-((meta-substituted) phenylglycine)-1-carba-1-dethiacephalosporins Download PDFInfo
- Publication number
- PT85850B PT85850B PT85850A PT8585087A PT85850B PT 85850 B PT85850 B PT 85850B PT 85850 A PT85850 A PT 85850A PT 8585087 A PT8585087 A PT 8585087A PT 85850 B PT85850 B PT 85850B
- Authority
- PT
- Portugal
- Prior art keywords
- carba
- phenyl
- acid
- chloro
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91517386A | 1986-10-03 | 1986-10-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT85850A PT85850A (en) | 1987-11-01 |
| PT85850B true PT85850B (en) | 1990-01-12 |
Family
ID=25435354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT85850A PT85850B (en) | 1986-10-03 | 1987-10-01 | Process for preparing 7-((meta-substituted) phenylglycine)-1-carba-1-dethiacephalosporins |
Country Status (17)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ227842A (en) * | 1988-02-05 | 1990-12-21 | Lilly Co Eli | Crystalline 2.5-hydrate form of a beta-lactam |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| SK287988B6 (sk) | 2001-01-26 | 2012-09-03 | Schering Corporation | Composition, oral dosage form and use thereof |
| AR035533A1 (es) | 2001-01-26 | 2004-06-02 | Schering Corp | Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| DE60206365T2 (de) | 2001-03-28 | 2006-07-06 | Schering Corporation, Kenilworth | Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten |
| AU2002336609B2 (en) | 2001-09-21 | 2006-08-24 | Merck Sharp & Dohme Corp. | Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| AU2003298513A1 (en) * | 2002-05-14 | 2004-05-13 | Northwestern University | STERICALLY-AWKWARD Beta-LACTAMASE INHIBITORS |
| WO2004043457A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| EP1601669B1 (en) | 2003-03-07 | 2008-12-24 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| MXPA05009502A (es) | 2003-03-07 | 2005-10-18 | Schering Corp | Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
| CN102144992B (zh) * | 2011-03-10 | 2013-04-10 | 浙江大学 | 苯基甘氨酸衍生物制备对金黄色葡萄球菌有抑菌和杀菌活性的抗菌剂的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3697515A (en) * | 1963-02-18 | 1972-10-10 | Ciba Geigy Corp | Process for splitting the 7-n-acyl group from cephalosporin compounds |
| NO155548C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
| NO155547C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling. |
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| JPS60174787A (ja) * | 1984-02-21 | 1985-09-09 | Kyowa Hakko Kogyo Co Ltd | ３位置換カルバセフエム化合物 |
| US4673737A (en) * | 1985-08-02 | 1987-06-16 | Harvard University | 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof |
-
1987
- 1987-10-01 CN CN198787107149A patent/CN87107149A/zh active Pending
- 1987-10-01 DE DE8787308713T patent/DE3780909T2/de not_active Expired - Fee Related
- 1987-10-01 ZA ZA877398A patent/ZA877398B/xx unknown
- 1987-10-01 AT AT87308713T patent/ATE79119T1/de not_active IP Right Cessation
- 1987-10-01 FI FI874311A patent/FI874311A7/fi not_active IP Right Cessation
- 1987-10-01 NZ NZ222015A patent/NZ222015A/xx unknown
- 1987-10-01 PT PT85850A patent/PT85850B/pt unknown
- 1987-10-01 EP EP87308713A patent/EP0266896B1/en not_active Expired - Lifetime
- 1987-10-01 IL IL84051A patent/IL84051A0/xx unknown
- 1987-10-02 KR KR870011038A patent/KR880005125A/ko not_active Withdrawn
- 1987-10-02 JP JP62250552A patent/JPS6396186A/ja active Pending
- 1987-10-02 BG BG081345A patent/BG47034A3/xx unknown
- 1987-10-02 IE IE872646A patent/IE872646L/xx unknown
- 1987-10-02 PL PL1987268034A patent/PL151703B1/pl unknown
- 1987-10-02 DK DK518487A patent/DK518487A/da not_active Application Discontinuation
- 1987-10-02 HU HU874452A patent/HU200179B/hu not_active IP Right Cessation
- 1987-10-08 AT AT0257587A patent/AT388377B/de active
-
1992
- 1992-10-08 GR GR920402240T patent/GR3005920T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK518487A (da) | 1988-04-04 |
| FI874311L (fi) | 1988-04-04 |
| GR3005920T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-06-07 |
| EP0266896A1 (en) | 1988-05-11 |
| BG47034A3 (bg) | 1990-04-16 |
| FI874311A0 (fi) | 1987-10-01 |
| FI874311A7 (fi) | 1988-04-04 |
| PT85850A (en) | 1987-11-01 |
| PL151703B1 (en) | 1990-09-28 |
| HU200179B (en) | 1990-04-28 |
| CN87107149A (zh) | 1988-05-18 |
| AT388377B (de) | 1989-06-12 |
| ATA257587A (de) | 1988-11-15 |
| ATE79119T1 (de) | 1992-08-15 |
| IL84051A0 (en) | 1988-03-31 |
| IE872646L (en) | 1988-04-03 |
| EP0266896B1 (en) | 1992-08-05 |
| JPS6396186A (ja) | 1988-04-27 |
| HUT45053A (en) | 1988-05-30 |
| DK518487D0 (da) | 1987-10-02 |
| AU7926987A (en) | 1988-04-14 |
| PL268034A1 (en) | 1988-09-01 |
| NZ222015A (en) | 1989-10-27 |
| DE3780909D1 (en) | 1992-09-10 |
| ZA877398B (en) | 1989-05-30 |
| AU591811B2 (en) | 1989-12-14 |
| DE3780909T2 (de) | 1993-03-04 |
| KR880005125A (ko) | 1988-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT85850B (en) | Process for preparing 7-((meta-substituted) phenylglycine)-1-carba-1-dethiacephalosporins | |
| JPS638116B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US4677100A (en) | Cephalosporin derivatives | |
| JPS5844675B2 (ja) | コウセイブツシツカゴウブツノ セイホウ | |
| DD282691A5 (de) | Verfahren zur herstellung von cephalosporin | |
| CA1048997A (en) | Cephalosporin derivatives | |
| AU615026B2 (en) | Crystalline beta-lactam solvate | |
| JPH03204883A (ja) | セファロスポリン化合物およびその用途 | |
| JPH0185A (ja) | 新規セフアロスポリン誘導体 | |
| US4018921A (en) | Substituted phenylglycylcephalosporins | |
| AU600536B2 (en) | Crystalline salts of {3s(z)}-2-{{{1-(2-amino-4-thiazolyl) -2-{{2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl}-amino-2- oxoethylidene}-amino}oxy}acetic acid | |
| US4492694A (en) | Indolylglycyl cephalosporin derivatives | |
| US4581352A (en) | Thienothienylglycyl cephalosporin derivatives | |
| US4482553A (en) | Benzothienylglycyl cephalosporin derivatives | |
| EP0731786B1 (en) | Biphenyl iodinated derivatives and their diagnostic use | |
| US4699981A (en) | Cephalosporin derivatives | |
| US3953439A (en) | Substituted phenylglycylcephalosporins | |
| WO2021043973A1 (en) | Siderophore cephalosporin conjugates and uses thereof | |
| US4490370A (en) | Naphthylglycyl cephalosporin derivatives | |
| AU637915B2 (en) | Cephalosporin derivatives with improved pharmacokinetics, process for their preparation, pharmaceutical compositions in which they are present and synthesis intermediate | |
| JPS59199692A (ja) | ベンゾチエニルグリシルセフアロスポリン誘導体 | |
| US4092480A (en) | Intermediates for preparing substituted phenylglycylcephalosporins | |
| US5407930A (en) | Cephalosporin derivatives | |
| EP0122155A2 (en) | Improvements in or relating to naphthylglycyl cephalosporin derivatives | |
| US5250725A (en) | Aromatic acid intermediates |